Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial
Negar Toroghi, Ladan Abbasian, Anahid Nourian, et al.
Pharmacological Reports (2021) Vol. 74, Iss. 1, pp. 229-240
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence
Carina Wagner, Mirko Griesel, Agata Mikołajewska, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 47
Low-dose versus high-dose dexamethasone for hospitalized patients with COVID-19 pneumonia: A randomized clinical trial
Huimin Wu, Salim Daouk, Jad Kebbe, et al.
PLoS ONE (2022) Vol. 17, Iss. 10, pp. e0275217-e0275217
Open Access | Times Cited: 34
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies
Elisa Souza Vaz, Sandra V. Vassiliades, Jeanine Giarolla, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 6, pp. 723-751
Open Access | Times Cited: 16
Corticosteroids in COVID-19: pros and cons
Aymen Bahsoun, Yeva Fakih, Rana Zareef, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 16
Corticosteroid Dosing Level, Incidence and Profile of Bacterial Blood Stream Infections in Hospitalized COVID-19 Patients
Ivan Papić, Petra Bistrović, Tomislav Čikara, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 86-86
Open Access | Times Cited: 6
High-Dose versus Low-Dose Corticosteroids in COVID-19 Patients: a Systematic Review and Meta-analysis
Rachel Si Jing Tan, Ka Ting Ng, Chua Ee Xin, et al.
Journal of Cardiothoracic and Vascular Anesthesia (2022) Vol. 36, Iss. 9, pp. 3576-3586
Open Access | Times Cited: 24
Guidance for prevention and management of COVID-19 in children and adolescents: A consensus statement from the Pediatric Infectious Diseases Society Pediatric COVID-19 Therapies Taskforce
Zachary Willis, Carlos R. Oliveira, Mark J. Abzug, et al.
Journal of the Pediatric Infectious Diseases Society (2024) Vol. 13, Iss. 3, pp. 159-185
Open Access | Times Cited: 4
Dosage and utilization of dexamethasone in the management of COVID-19: A critical review
Imran Sethi, Asim Shaikh, Musa Sethi, et al.
World Journal of Virology (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 4
Glucocorticoid Therapy in COVID-19
Francesco Amati, Antonio Tonutti, John C. Huston, et al.
Seminars in Respiratory and Critical Care Medicine (2023) Vol. 44, Iss. 01, pp. 100-117
Closed Access | Times Cited: 9
Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalised adults with severe COVID‐19 pneumonia: An open‐label randomised trial
Luís Corral-Gudino, Iván Cusacovich, José Ignacio Martín‐González, et al.
European Journal of Clinical Investigation (2022) Vol. 53, Iss. 1
Open Access | Times Cited: 15
Corticosteroids induce an early but limited decrease in IL-6 dependent pro-inflammatory responses in critically ill COVID-19 patients
Tomas Urbina, Paul Gabarre, Vincent Bonny, et al.
Minerva Anestesiologica (2024) Vol. 90, Iss. 3
Closed Access | Times Cited: 2
Effects of corticosteroid treatment in patients with severe fever with thrombocytopenia syndrome: A single-center retrospective cohort study
Leiqun Xiong, Ling Xu, Xiaoying Lv, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 1026-1033
Open Access | Times Cited: 11
Effect of dexamethasone dose on outcomes in acute COVID-19 disease: A systematic review and meta-analysis
Timothy Arthur Chandos Snow, Nishkantha Arulkumaran, Mervyn Singer, et al.
Journal of Infection (2023) Vol. 87, Iss. 6, pp. 490-497
Closed Access | Times Cited: 6
Efficacy and safety of glucocorticoids use in patients with COVID-19: a systematic review and network meta‑analysis
Qiaolan He, Chen Wang, Yingqin Wang, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
High-Dose Corticosteroid Use in Severe to Critically Ill Patients With COVID-19: A Nationwide Population-Based Matched Cohort Study
Raeseok Lee, Sung‐Yeon Cho, Dong‐Gun Lee, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 34
Open Access | Times Cited: 1
Associations between corticosteroid dosage and clinical outcomes in patients with hypoxemic COVID-19 pneumonia: A retrospective cohort study
Napassorn Teeratakulpisarn, Supattra Chiewroongroj, Thummaporn Naorungroj, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0308069-e0308069
Open Access | Times Cited: 1
Lidocaine reinforces the anti-inflammatory action of dexamethasone on myeloid and epithelial cells activated by inflammatory cytokines or SARS-CoV-2 infection
Maia Lina Elizagaray, Ignacio Mazitelli, Andrea Pontoriero, et al.
Biomedical Journal (2022) Vol. 46, Iss. 1, pp. 81-92
Open Access | Times Cited: 8
Higher- versus Lower-Dose Corticosteroids for Severe to Critical COVID-19: A Systematic Review and Dose–Response Meta-analysis
Tyler Pitre, Johnny Su, Jasmine Mah, et al.
Annals of the American Thoracic Society (2022) Vol. 20, Iss. 4, pp. 596-604
Open Access | Times Cited: 8
Case Report of a Fatal Babesia vulpes Infection in a Splenectomised Dog
Maria Sophia Unterköfler, Nikola Pantchev, Carina Bergfeld, et al.
Parasitologia (2023) Vol. 3, Iss. 1, pp. 59-68
Open Access | Times Cited: 4
Analogies between COVID-19 and Preeclampsia: Focus on Therapies
Valentina Giardini, Carlo Gambacorti‐Passerini, Marco Casati, et al.
International Journal of Translational Medicine (2023) Vol. 3, Iss. 2, pp. 203-216
Open Access | Times Cited: 4
Intermediate- to high-dose dexamethasone versus low-dose dexamethasone in patients with COVID-19 requiring respiratory support: a systematic review and meta-analysis of randomized trials
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2773-2779
Open Access | Times Cited: 4
Anti‐inflammatory effects of dexamethasone in COVID‐19 patients: Translational population PK/PD modeling and simulation
Artur Świerczek, William J. Jusko
Clinical and Translational Science (2023) Vol. 16, Iss. 9, pp. 1667-1679
Open Access | Times Cited: 4
Impact of corticosteroid doses on prognosis of severe and critical COVID-19 patients with Omicron variant infection: a propensity score matching study
Shiyao Wang, Ziying Chen, X. Y. Zhang, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 3347-3356
Open Access | Times Cited: 1
Coagulopathy in COVID-19 and anticoagulation clinical trials
Heng Zhang, Qifang Lao, Jue Zhang, et al.
Best Practice & Research Clinical Haematology (2022) Vol. 35, Iss. 3, pp. 101377-101377
Open Access | Times Cited: 6
Adverse cognitive effects of glucocorticoids: A systematic review of the literature
Liam Spannenburg, Hayley Reed
Steroids (2023) Vol. 200, pp. 109314-109314
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top